Prospective health care: the second transformation of medicine.
Publication
, Journal Article
Snyderman, R; Langheier, J
Published in: Genome Biol
2006
Emerging scientific technologies provide rich sources of predictive biomarkers, which could transform health care. Identification of causal biomarkers will enable the development of tools to quantify risk and anticipate disease. Accurate health risk analysis is rapidly becoming feasible, so health care can become rational, preventive and personalized.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Genome Biol
DOI
EISSN
1474-760X
Publication Date
2006
Volume
7
Issue
2
Start / End Page
104
Location
England
Related Subject Headings
- United States
- Science
- Risk Assessment
- Medicine
- Humans
- Genomics
- Delivery of Health Care
- Cost of Illness
- Chronic Disease
- Biomarkers
Citation
APA
Chicago
ICMJE
MLA
NLM
Snyderman, R., & Langheier, J. (2006). Prospective health care: the second transformation of medicine. Genome Biol, 7(2), 104. https://doi.org/10.1186/gb-2006-7-2-104
Snyderman, Ralph, and Jason Langheier. “Prospective health care: the second transformation of medicine.” Genome Biol 7, no. 2 (2006): 104. https://doi.org/10.1186/gb-2006-7-2-104.
Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol. 2006;7(2):104.
Snyderman, Ralph, and Jason Langheier. “Prospective health care: the second transformation of medicine.” Genome Biol, vol. 7, no. 2, 2006, p. 104. Pubmed, doi:10.1186/gb-2006-7-2-104.
Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol. 2006;7(2):104.
Published In
Genome Biol
DOI
EISSN
1474-760X
Publication Date
2006
Volume
7
Issue
2
Start / End Page
104
Location
England
Related Subject Headings
- United States
- Science
- Risk Assessment
- Medicine
- Humans
- Genomics
- Delivery of Health Care
- Cost of Illness
- Chronic Disease
- Biomarkers